NSCI - Sale or liquidation may be on the cards...
Posted: December 3rd, 2018, 11:41 am
Interesting developments afoot at NetScientific (NSCI)
Who? I hear you collectively say, as I suspect no-one will have heard of NSCI!
===============
About NetScientific - NSCI is a transatlantic healthcare technology group with an investment strategy focused on sourcing, funding and commercialising technologies that significantly improve the health and well-being of people with chronic diseases. For more information, please visit the website at www.NetScientific.net
================
The ski-slope chart shown on ADVFN’s PE thread (see link at the bottom of this post) tells its own story; but it has also prompted the BoD to be realistic as to its prospects. Accordingly we saw this statement last week (edited for brevity):
“Strategic review including formal sale process under the Takeover Code:
NSCI, the transatlantic healthcare IP commercialisation group, announces today that it has decided to conduct a review of the various strategic options open to it (the "Strategic Review"), one of which is a sale of the Company.
The Company has made recent significant progress against strategic milestones in its portfolio companies………The Board believes that the market is undervaluing NetScientific's portfolio. Therefore, the Board has determined that it is appropriate to evaluate all options, including a sale of the Company or certain of its portfolio companies, to maximise value for shareholders.”
<a href='https://uk.advfn.com/stock-market/london/netscientific-NSCI/share-news/NetScientific-PLC-Announcement-of-Strategic-Review/78757626' target='window'>https://uk.advfn.com/stock-market/london/netscientific-NSCI/share-news/NetScientific-PLC-Announcement-of-Strategic-Review/78757626</a>
I’ve bought a few this morning, having patiently sat on my hands over recent months waiting for a base to form. With the likely NAV well over double the current 28p share price, a small speculative position may well reward. Worth a look at any rate…
https://uk.advfn.com/cmn/fbb/thread.php3?id=26570589
Who? I hear you collectively say, as I suspect no-one will have heard of NSCI!
===============
About NetScientific - NSCI is a transatlantic healthcare technology group with an investment strategy focused on sourcing, funding and commercialising technologies that significantly improve the health and well-being of people with chronic diseases. For more information, please visit the website at www.NetScientific.net
================
The ski-slope chart shown on ADVFN’s PE thread (see link at the bottom of this post) tells its own story; but it has also prompted the BoD to be realistic as to its prospects. Accordingly we saw this statement last week (edited for brevity):
“Strategic review including formal sale process under the Takeover Code:
NSCI, the transatlantic healthcare IP commercialisation group, announces today that it has decided to conduct a review of the various strategic options open to it (the "Strategic Review"), one of which is a sale of the Company.
The Company has made recent significant progress against strategic milestones in its portfolio companies………The Board believes that the market is undervaluing NetScientific's portfolio. Therefore, the Board has determined that it is appropriate to evaluate all options, including a sale of the Company or certain of its portfolio companies, to maximise value for shareholders.”
<a href='https://uk.advfn.com/stock-market/london/netscientific-NSCI/share-news/NetScientific-PLC-Announcement-of-Strategic-Review/78757626' target='window'>https://uk.advfn.com/stock-market/london/netscientific-NSCI/share-news/NetScientific-PLC-Announcement-of-Strategic-Review/78757626</a>
I’ve bought a few this morning, having patiently sat on my hands over recent months waiting for a base to form. With the likely NAV well over double the current 28p share price, a small speculative position may well reward. Worth a look at any rate…
https://uk.advfn.com/cmn/fbb/thread.php3?id=26570589